The effects of exogenous mouse interferon on the MJY-alpha mammary tumor cell line chronically infected with mouse mammary tumor virus (MMTV) were examined. Interferon at concentrations of 25 to 2,000 IU/ml in culture medium did not alter the growth rate or morphology of the cell layers. Electron microscopic examination of interferon-treated cells indicated a decrease in the numbers of Atype and budding B-type particles of MMTV. However, the levels of extracellular MMTV virions in the culture supernatants were not significantly reduced. Profiles of MMTV glycoproteins and nonglycosylated polypeptides obtained by sodium dodecyl sulfate-polyacrylamide gel electrophoresis of virions purified from interferon-treated cultures revealed increases in the relative levels of the 60,000-dalton glycoprotein, gp6O.
Interferon is a natural determinant of host resistance to viral infection. There is a strong indication that interferon responses of host cells may complement the host immune system and contribute to host resistance to neoplasia induced by retroviruses (11, 14, 19) . In vivo studies have suggested that interferon acts by inhibiting development or proliferation of neoplastic cells rather than by decreasing viral infection and replication (8, 11, 26) .
Studies examining the effects of interferon on in vitro cell cultures have demonstrated that exogenous interferon significantly inhibits production of virus particles in cells infected with murine leukemia virus (MuLV; 1, 25, 35) . The mechanism(s) of reduction of viral synthesis is unknown; decreases were observed only when interferon was present in the cultures. Similar reversible depression of murine mammary tumor virus (MMTV) production was reported to occur in the Mm5mt/c, C3H mammary tumor cell line when treated with 10 to 100 U of interferon per ml (33) . The reduction in MMTV replication was dose dependent and was observed after a 12-to 16-h treatment period. These workers did not observe any changes in expression of MMTV-related antigens in treated cells by immunofluorescence, although cellular MMTV-specific RNA-dependent DNA polymerase levels were significantly reduced. They postulated that interferon inhibition may be due to its action both on MMTV protein synthesis and on viral assembly and maturation.
We have examined the effects of exogenous mouse interferons on the replication of MMTV in the chronically infected mammary tumor cell 225 line MJY-alpha. The results reported here indicate that interferon does not induce a significant reduction of MMTV virion synthesis but does alter the polypeptide pattern of MMTV proteins.
MATERIALS AND METHODS Cells. The MMTV-producing MJY-alpha cell line was grown as stationary cultures in T-flasks or petri dishes as previously described (36) . Growth medium for all cultures was RPMI 1640 supplemented with 20% fetal calf serum, 10-5 M bovine insulin, and antibiotics (36) . Cells were incubated at 37°C in a humidified atmosphere of 5% CO2 in air. Cultures were routinely checked for bacterial, fungal, and Mycoplasma contamination (36) ; the results were negative.
Production and purification of mouse interferon. Mouse interferon was produced by infection of the murine C-243 cell line with Newcastle disease virus (3) . Supernatants from infected cultures were cleared by centrifugation at 100,000 x g for 2 h, concentrated 2.5-fold by ultrafiltration (Amicon UM-2 membrane with 1,000-molecular-weight exclusion limit), and dialyzed for 20 h against 0.05 M sodium acetate buffer, pH 5.0. Interferon was purified by affinity chromatography using Affi-Gel 202 (Bio-Rad Laboratories) in a column (0.9 by 10 cm) equilibrated with acetate buffer. A flow rate of 17 ml/h was maintained by means of an LKB peristaltic pump. After the breakthrough fraction, the column was equilibrated with 0.02 M sodium phosphate buffer, pH 7.4, followed by elution with 0.2 M sodium phosphate containing 0.5 M sodium chloride, pH 7.4. Portions of the 1.0-ml fractions were assayed for both protein and interferon concentrations. The specific activity of the purified mouse interferon was 7.0 x 10' IU per mg of protein.
Mouse interferon samples from two other sources were used for comparative analyses to confirm the results obtained with interferon produced and purified MJY-alpha cell layers grown in 25-ml T-flasks or J. VIROL.
petri dishes were processed for electron microscopy as previously described (21, 36 gradient gels and a discontinuous buffer system (40, 41) . Gels were processed for determination of radioactivity as described by Compans (12 with the cell layers for 24 h at 37°C did not significantly reduce the levels of interferon activity in the medium. The daily addition of interferon at concentrations of 50 to 1,000 IU per ml of medium had no effect on the growth rate or release of viable cells from the monolayers (Fig. 1) (Fig. 2) . Thin sections revealed no detectable differences between these control cultures and cells treated for 1 to 4 days with interferon at concentrations of 20, 50, 100, 200, 500, and 1,000 IU/ml. During the 4-day incubation in the presence of hydrocortisone and interferon, there was a progressive increase in the number of cytoplasmic and budding viral particles in the cells which paralleled that observed in control MJY-alpha cells during comparable time periods. However, in a similar study using 2,000 IU of interferon per ml, a reduction in the numbers of viral particles was observed after 4 days of treatment. This reduction, which was not observed during the first 3 days of incubation with the same concentration of interferon, was most obvious when the numbers of intracytoplasmic A-type particles were compared in the control and interferon-treated cultures at 4 days. There appeared to be fewer and smaller aggregates of A-type particles present in the interferon-treated cells. In addition, a decrease in the number of microvilli and budding particles was also observed (Fig. 3) . Interferon 25 , 50, 100, and 1,000 IU of interferon per ml of medium for 24 to 72 h revealed increases in the levels of the 60,000-dalton glycoprotein, gp60 (Fig. 4) . The increase of gp6O was greater for virions from cultures treated with 1,000 IU of interferon per ml than for virions from cultures treated with the lower concentrations.
However, the differences were not proportional, suggesting that the effect exerted by interferon on the glycoprotein of MMTV is not dose dependent. The increase of gp6O relative to the other MMTV polypeptides and glycoproteins was observed in virions from cultures pretreated with interferon for 24 to 48 h before labeling as well as in virions from cultures which also contained hydrocortisone in the medium. Similar changes in the level of gp6O were observed when interferons I-F and I-LB were used (Fig. 4 and Table 2 ).
DISCUSSION
The results presented here demonstrate that treatment of MJY-alpha cells with 25 to 2,000 IU of interferon per ml did not significantly reduce extracellular production of MMTV virions. In contrast, a previous in vitro study using the mammary tumor cell line Mm5mt/c, chronically infected with MMTV detected a 5-to 10-fold reduction in MMTV replication by quantitation of extracellular RNA-dependent DNA polymerase activity (33) . This inhibition was observed when the glucocorticoid-stimulated cultures were treated for periods of 12 to 16 h with 10 to 100 IU of interferon per ml. The lack of inhibition of MMTV virions observed in the MJY-alpha cell line is not attributable to the source or purity of interferon, since similar results were obtained with interferon purified in our laboratory as well as interferon obtained from two other sources. The differences in inhibition of MMTV replication may be due to the sensitivity of the two cell lines to the antiviral action of mouse interferons. CPE induced by encephalomyocarditis virus was reduced in Mm5mt/c, cells at a 3-to 10-fold-lower level by interferon than in Ly mouse cells, whereas CPE induced by VSV in MJY-alpha cells was reduced 4-to 16-fold when compared with L cells examined in parallel. Similar phenomena have been reported for mouse cell lines chronically infected with MuLV. In these studies, the degree of reduction of retrovirus replication appears to be related to the sensitivity of the cell line to interferon-induced protection against cytopathic viral infection (4, 6, 10, 15, 16, 25) . Our results also demonstrate the variability in the degree of interferon sensitivity of mouse mammary tumor cells chronically producing MMTV. Further examination of primary or short-term mammary tumor cell cultures is necessary to determine whether newly arising mammary tumors also exhibit a range of sensitivity to interferon.
Electron microscopic examination of interferon-treated MJY-alpha cells did not reveal detectable ultrastructural changes in cellular organelles or in the appearance of MMTV A-type or of budding or mature B-type particles that would account for the elevated levels of the specific virion-associated glycoprotein, gp6O. The numbers of virions detected in control and parallel cultures treated with 100 to 1,000 IU of interferon per ml were also similar. Cultures (----) and '4C-amino acids ( ) for 24 h. (A) Untreated control cultures; (B) cultures pretreated with 1,000 IU of interferon per ml for 24 h before addition of isotopic labels; (C) cultures pretreated uith 1,000 IU of interferon (I-F) per (39) . The interrelationship of gp6O and the other polypeptides of MMTV has not yet been established. There is evidence from our previous study (40) and that of Sheffield et al. (31) that the cleavage products, gp22 and gp36, are derived from gp6O or gp52, and we have suggested that gp6O may be an uncleaved form of the major virion glycoproteins. Our cumulative findings indicate that the presence of gp6O in mature B-type virions is related to the environment of the MJY-alpha cells, although the mechanism by which exogenous antibody and interferon increase gp6O is unknown. Investigators studying the effects of interferon on Moloney murine leukemia virus replication in a fibroblastic cell line (TB) have also reported elevated levels of a large glycoprotein, gp85, associated with mature virions (9) . These workers suggested that gp85 was related to a glycoprotein precursor of the major viral glycoprotein gp69/71, and that interferon acted by inhibiting a cleavage step in the maturation of C-type particles.
It is probable that such inhibition of proteolytic cleavage is related to or is the consequence of the action of interferon on the plasma membranes of the infected cells (2, 9) . It is not known whether exogenous antibody against the virion polypeptides exerts its action in a similar manner. Unlike interferon treatment, addition of antiviral antibody to MJY-alpha cell cultures induces a significant and rapid decrease in MMTV production (39) . Studies examining the effects of antibody against measles virus have shown that exogenous immunoglobulins do induce cytoplasmic changes in the synthesis and processing of viral polypeptides as well as removal of virions from the cell surfaces (17) . In light of these results, further studies are needed to determine whether interferon and antibody treatments also induce detectable changes in the composition of the plasma membranes of MJYalpha cells as well as in the viral components in the cytosol.
Our in vitro studies indicate that interferon does alter MMTV replication in mammary tumor cells. The biological consequences of increased levels of gp6O in MMTV B-type particles are unknown, although it was reported that MuLV virions containing interferon-induced increases of gp85 had reduced levels of infectivity (9) . It is possible that interferon treatment of MMTV-infected cells could effectively reduce viremia and subsequent secondary infection and neoplastic transformation of mammary parenchyma by decreasing the levels of MMTV replication and by altering the infectivity of the virions (13, 24, 30) . Previous studies by Came and Moore (8) and Bekesi et al. (3) indicate that exogenous interferon is effective in delaying the development and growth of mammary tumors as well as in restoring the hosts' cell-mediated immunity and abrogating the suppressor cell population. It is probable that the protection afforded the host by interferon treatment is mediated by the dual action of interferon on viral replication and the immune system (18, 20, 23, 29, 32) . Studies are in progress to determine whether in vitro treatment of MJY-alpha cells with interferon alters the tumorigenicity of the cells in syngeneic hosts and to analyze the viral and cellular compositions of MJY-alpha-induced tumors in hosts treated with interferon.
